View in EDS

Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.

Saved in:
Bibliographic Details
Title: Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
Authors: Rousel J; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Bergmans ME; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands., van der Meulen LWJ; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands., Pagan L; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands., de Bruin DT; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands., de Kam ML; Centre for Human Drug Research, Leiden, The Netherlands., Klarenbeek NB; Centre for Human Drug Research, Leiden, The Netherlands., Bouwstra JA; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Seyger MMB; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., van den Reek JMPA; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands., Niemeyer-van der Kolk T; Centre for Human Drug Research, Leiden, The Netherlands., Rissmann R; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands. Electronic address: rrissmann@chdr.nl., van Doorn MBA; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Corporate Authors: NGID consortium
Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 395-397. Date of Electronic Publication: 2023 Oct 05.
Publication Type: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37804933
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Rousel+J%22">Rousel J</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bergmans+ME%22">Bergmans ME</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Meulen+LWJ%22">van der Meulen LWJ</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Pagan+L%22">Pagan L</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Bruin+DT%22">de Bruin DT</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Kam+ML%22">de Kam ML</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Klarenbeek+NB%22">Klarenbeek NB</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bouwstra+JA%22">Bouwstra JA</searchLink>; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Seyger+MMB%22">Seyger MMB</searchLink>; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+den+Reek+JMPA%22">van den Reek JMPA</searchLink>; Department of Dermatology, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Niemeyer-van+der+Kolk+T%22">Niemeyer-van der Kolk T</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rissmann+R%22">Rissmann R</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands; Leiden University Medical Center, Leiden, The Netherlands. Electronic address: rrissmann@chdr.nl.<br /><searchLink fieldCode="AU" term="%22van+Doorn+MBA%22">van Doorn MBA</searchLink>; Centre for Human Drug Research, Leiden, The Netherlands; Department of Dermatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22NGID+consortium%22">NGID consortium</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227907132%22">Journal of the American Academy of Dermatology</searchLink> [J Am Acad Dermatol] 2024 Feb; Vol. 90 (2), pp. 395-397. <i>Date of Electronic Publication: </i>2023 Oct 05.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Mosby%22">Mosby </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7907132 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-6787 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201909622%22">01909622 </searchLink><i>NLM ISO Abbreviation: </i>J Am Acad Dermatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37804933
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.jaad.2023.09.071
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 395
    Titles:
      – TitleFull: Guselkumab induction therapy demonstrates long-lasting efficacy in patients with mild psoriasis, results from a randomized, placebo-controlled exploratory clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Rousel J
      – PersonEntity:
          Name:
            NameFull: Bergmans ME
      – PersonEntity:
          Name:
            NameFull: van der Meulen LWJ
      – PersonEntity:
          Name:
            NameFull: Pagan L
      – PersonEntity:
          Name:
            NameFull: de Bruin DT
      – PersonEntity:
          Name:
            NameFull: de Kam ML
      – PersonEntity:
          Name:
            NameFull: Klarenbeek NB
      – PersonEntity:
          Name:
            NameFull: Bouwstra JA
      – PersonEntity:
          Name:
            NameFull: Seyger MMB
      – PersonEntity:
          Name:
            NameFull: van den Reek JMPA
      – PersonEntity:
          Name:
            NameFull: Niemeyer-van der Kolk T
      – PersonEntity:
          Name:
            NameFull: Rissmann R
      – PersonEntity:
          Name:
            NameFull: van Doorn MBA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 02
              Text: 2024 Feb
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1097-6787
          Numbering:
            – Type: volume
              Value: 90
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Journal of the American Academy of Dermatology
              Type: main
ResultId 1